Introduction
Drug distribution is a complex field that connects manufacturers, distributors, and pharmacists. Distributors sit in the middle, making sure medicines reach hospitals, clinics, and pharmacies on time. In the United States, three companies dominate this space, and they are collectively known as the "Big 3."
This article looks at who they are, how large they are, and what services they provide.
Who Are the Big 3?
The Big 3 drug distributors in the United States are McKesson Corporation, AmerisourceBergen Corporation, and Cardinal Health, Inc. Together, they account for more than 90% of the U.S. pharmaceutical distribution market.
McKesson Corporation
McKesson is the oldest and largest of the three. It was founded in 1833 and is headquartered in San Francisco, California. With US$ 214 billion in revenue in 2020, it ranks as the fifth largest company in the United States. The company operates in more than 16 countries.
McKesson delivers roughly one-third of the medicines used daily in North America. Beyond distribution, it also provides healthcare technology solutions, including electronic health records, revenue cycle management software, and pharmacy automation systems.
AmerisourceBergen Corporation
AmerisourceBergen is headquartered in Chesterbrook, Pennsylvania. It was formed in 2001 through the merger of AmeriSource Health and Bergen Brunswig. With US$ 195 billion in revenue in 2020, it ranks as the 12th largest company in the United States.
The company operates more than 30 distribution centers in the U.S. and has a presence in over 50 countries. In addition to distribution, it offers consulting and outsourcing services such as revenue cycle management, clinical trial support, and patient assistance programs.
Cardinal Health, Inc.
Cardinal Health is headquartered in Dublin, Ohio. It was founded in 1971 and has grown into one of the largest drug distributors in the world. With US$ 152 billion in revenue in 2020, it ranks as the 19th largest company in the United States.
Its distribution network covers more than 60,000 locations in the U.S. and operates in over 40 countries. Besides distribution, Cardinal Health offers medical and surgical products, laboratory services, and healthcare consulting.
Big 3 at a Glance
| Company | Founded | 2020 Revenue | Global Reach |
|---|---|---|---|
| McKesson | 1833 | US$ 214B | 16+ countries |
| AmerisourceBergen | 2001 | US$ 195B | 50+ countries |
| Cardinal Health | 1971 | US$ 152B | 40+ countries |
Frequently Asked Questions
|
Q1. Why are they called the "Big 3"? Because McKesson, AmerisourceBergen, and Cardinal Health together control over 90% of the U.S. pharmaceutical distribution market. No other distributors come close in scale. |
Q2. Do they only distribute drugs? No. All three also provide healthcare technology, consulting, and logistics services. McKesson offers EHR and pharmacy automation; AmerisourceBergen offers clinical trial support; Cardinal Health offers medical and surgical products. |
|
Q3. Where do the drugs come from before distribution? They come from pharmaceutical manufacturers and API suppliers. Many of these upstream suppliers are based in China and India, producing pharmaceutical intermediates and active ingredients that later enter the global distribution chain. |
If you are sourcing pharmaceutical intermediates or APIs upstream of the distribution chain, contact Alfa Chemical for a quote and batch-specific COA.
RELATED RESOURCES